Lilly Diabetes Australia has
announced the release of its new
HumaPen SAVVIO, an insulin
delivery device for use with the
Humalog and Humulin insulins.
The pen is designed from patient
feedback in a range of colours.
“Based on our research, we
learned that people with diabetes
want an insulin delivery device that
makes them feel more comfortable
managing their insulin,” said Ciara
McKenna, Director of Lilly Diabetes
Australia.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Nov 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.